AcelRx Pharmaceuticals Inc's shares surged 30 percent on Wednesday after U.S. Food and Administration staff said the company's opioid treatment was safe and effective, bringing it one step closer to a marketing approval.

https://ift.tt/2RDel5w support@endlesssupplies.biz (Endless Supplies .Biz) October 10, 2018 at 01:03PM
No comments:
Post a Comment